‘Landmark moment’ for cancer patients as thousands to receive personalised vaccines in NHS trial.
31 May 2024, 06:07 | Updated: 31 May 2024, 06:09
Thousands of NHS cancer patients in England will get personalised vaccines over the next year to help fight their disease in what has been described as a ‘landmark’ moment for treatment.
Early results of the vaccine, made by BioNTech, will be presented at the American Society of Clinical Oncology's annual conference on Friday.
Dozens of patients have started receiving the vaccines and thousands are expected to enrol by 2026. LBC.